ovarian neoplasm
Showing 1 - 25 of 31
Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)
Not yet recruiting
- Ovarian Cancer
- +5 more
- MIRRORS Protocol
- Standard Open Cytoreductive Surgery
- (no location specified)
Jul 17, 2023
Breast Cancer, Ovarian Tumor, Pain Trial in Albuquerque (Omega-3 fatty acid, Placebo, Paclitaxel)
Completed
- Breast Cancer
- +2 more
- Omega-3 fatty acid
- +2 more
-
Albuquerque, New Mexico
- +1 more
Oct 4, 2022
Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed
Completed
- Ovarian Neoplasm
- +4 more
- (no location specified)
Aug 22, 2022
Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)
Completed
- Carcinoma
- +12 more
- Ocoxin-Viusid
-
Havana, CubaNational Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022
Sarcoma, Ovarian Tumor, CNS Tumor Trial in Villejuif (Pembrolizumab)
Active, not recruiting
- Sarcoma
- +6 more
-
Villejuif, FranceGustave Roussy Cancer Campus
Mar 28, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Ovarian Tumor, Uterine Tumor Trial in Winston-Salem (Informational Intervention, Questionnaire Administration, Telephone-Based
Completed
- Ovarian Neoplasm
- Uterine Neoplasm
- Informational Intervention
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Nov 5, 2021
Ovarian Cancer, Tumor, Ovarian, Ovarian Tumor Trial in Xi'an (chemo, targeted therapeutics, immunotherapy, IFRT, IMRT or SBRT)
Recruiting
- Ovarian Cancer
- +16 more
- chemotherapy, targeted therapeutics, immunotherapy
- IFRT, IMRT or SBRT
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Xi'an Jiao Tong University
Sep 25, 2021
Ovarian Tumor Trial in Bordeaux (Arm A : intraoperative ANI monitoring of nociception, Arm B : no specific monitoring of
Not yet recruiting
- Ovarian Neoplasm
- Arm A : intraoperative ANI monitoring of nociception
- Arm B : no specific monitoring of nociception
-
Bordeaux, FranceInstitut BergoniƩ
May 27, 2021
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Guildford (Dietary intervention)
Recruiting
- Colorectal Cancer
- +10 more
- Dietary intervention
-
Guildford, Surrey, United KingdomRoyal Surrey NHS Foundation Trust
May 18, 2021
Cancer Diagnosis and Treatment on Everyday Life
Active, not recruiting
- Breast Cancer Female
- +17 more
-
Aberystwyth, United Kingdom
- +110 more
Mar 16, 2021
Ovarian Tumor, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial run by the NCI (Bevacizumab, BAY 43-9006)
Completed
- Ovarian Neoplasm
- +2 more
- Bevacizumab
- BAY 43-9006
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 3, 2020
Finisterian Patients Treated With PARP Inhibitors for Ovarian
Completed
- Ovarian Neoplasm
-
Brest, France
- +3 more
Sep 28, 2020
Minimally Invasive Robotic Surgery, Role in Optimal Debulking
Recruiting
- Ovarian Cancer
- +4 more
- Robotic Interval Debulking Surgery
-
Guildford, Surrey, United KingdomRoyal Surrey NHS Foundation Trust
Aug 31, 2020
Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Completed
- Breast Carcinoma
- +3 more
- Evaluation of Cancer Risk Factors
- +3 more
-
Birmingham, Alabama
- +140 more
Aug 31, 2020
Test in Ovarian Cancer Remission to See if Protein Changes Can
Completed
- Ovarian Neoplasm
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 11, 2020
Female Reproductive System Tumor, Malignant Female Reproductive System Tumor, Malignant Uterine Tumor Trial in Winston-Salem
Completed
- Female Reproductive System Neoplasm
- +6 more
- Questionnaire Administration
- Supportive Care
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Dec 20, 2019
Family Communication of Hereditary Breast and Ovarian Cancer
Terminated
- Ovarian Neoplasm
- +2 more
-
Bethesda, MarylandNational Human Genome Research Institute (NHGRI), 9000 Rockville
Nov 30, 2019
Ovarian Tumor Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))
Completed
- Ovarian Neoplasm
- KU-0059436 (AZD2281)(PARP inhibitor)
-
Los Angeles, California
- +10 more
Jul 4, 2018
Ovarian Tumor Trial run by the NCI (Cyclophosphamide, Paclitaxel, Cisplatin)
Completed
- Ovarian Neoplasm
- Cyclophosphamide
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 4, 2018
Ovarian Tumor Trial run by the NCI (aldesleukin, incomplete Freund's adjuvant, p53 peptide vaccine)
Terminated
- Ovarian Neoplasm
- aldesleukin
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 5, 2017
Microarray Analysis for Human Genetic Disease
Completed
- Breast Neoplasm
- +3 more
-
Tucson, Arizona
- +7 more
Jun 30, 2017